Prostate cancer risk SNP rs10993994 is a trans-eQTL for SNHG11 mediated through MSMB

Hum Mol Genet. 2020 Jun 27;29(10):1581-1591. doi: 10.1093/hmg/ddaa026.

Abstract

How genome-wide association studies-identified single-nucleotide polymorphisms (SNPs) affect remote genes remains unknown. Expression quantitative trait locus (eQTL) association meta-analysis on 496 prostate tumor and 602 normal prostate samples with 117 SNPs revealed novel cis-eQTLs and trans-eQTLs. Mediation testing and colocalization analysis demonstrate that MSMB is a cis-acting mediator for SNHG11 (P < 0.01). Removing rs10993994 in LNCaP cell lines by CRISPR/Cas9 editing shows that the C-allele corresponds with an over 100-fold increase in MSMB expression and 5-fold increase in SNHG11 compared with the T-allele. Colocalization analysis confirmed that the same set of SNPs associated with MSMB expression is associated with SNHG11 expression (posterior probability of shared variants is 66.6% in tumor and 91.4% in benign). These analyses further demonstrate variants driving MSMB expression differ in tumor and normal, suggesting regulatory network rewiring during tumorigenesis.

Publication types

  • Meta-Analysis
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • CRISPR-Cas Systems
  • Cell Line, Tumor
  • Gene Editing
  • Gene Expression Regulation / genetics
  • Genetic Predisposition to Disease*
  • Genome-Wide Association Study
  • Genotype
  • Humans
  • Male
  • Polymorphism, Single Nucleotide / genetics
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / pathology
  • Prostatic Secretory Proteins / genetics*
  • Quantitative Trait Loci / genetics
  • RNA, Long Noncoding / genetics*
  • RNA, Untranslated / genetics*

Substances

  • Prostatic Secretory Proteins
  • RNA, Long Noncoding
  • RNA, Untranslated
  • beta-microseminoprotein